

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74850670 |
| 2 | positive regulation of T cell cytokine production (GO:0002726) | 3.69298294 |
| 3 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41693463 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.35417998 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.34766122 |
| 6 | tachykinin receptor signaling pathway (GO:0007217) | 3.29285785 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20347302 |
| 8 | metallo-sulfur cluster assembly (GO:0031163) | 3.17681641 |
| 9 | iron-sulfur cluster assembly (GO:0016226) | 3.17681641 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 3.16000220 |
| 11 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.15490329 |
| 12 | positive regulation of interleukin-2 production (GO:0032743) | 3.10418745 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09993593 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 3.04603240 |
| 15 | ADP metabolic process (GO:0046031) | 2.99478979 |
| 16 | mature B cell differentiation (GO:0002335) | 2.98519799 |
| 17 | cytidine deamination (GO:0009972) | 2.96674028 |
| 18 | cytidine metabolic process (GO:0046087) | 2.96674028 |
| 19 | cytidine catabolic process (GO:0006216) | 2.96674028 |
| 20 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94225587 |
| 21 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.90341732 |
| 22 | actin-myosin filament sliding (GO:0033275) | 2.89623846 |
| 23 | muscle filament sliding (GO:0030049) | 2.89623846 |
| 24 | cellular response to exogenous dsRNA (GO:0071360) | 2.89602952 |
| 25 | response to host immune response (GO:0052572) | 2.86140576 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.86140576 |
| 27 | dendritic cell chemotaxis (GO:0002407) | 2.82699987 |
| 28 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81799978 |
| 29 | negative regulation of cell killing (GO:0031342) | 2.81701707 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81701707 |
| 31 | piRNA metabolic process (GO:0034587) | 2.81199755 |
| 32 | tryptophan catabolic process (GO:0006569) | 2.80648417 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 2.80648417 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 2.80648417 |
| 35 | skeletal muscle contraction (GO:0003009) | 2.78550597 |
| 36 | regulation of relaxation of muscle (GO:1901077) | 2.78154837 |
| 37 | T cell migration (GO:0072678) | 2.78082166 |
| 38 | protein ADP-ribosylation (GO:0006471) | 2.77175464 |
| 39 | cellular response to zinc ion (GO:0071294) | 2.74999961 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74669607 |
| 41 | mature B cell differentiation involved in immune response (GO:0002313) | 2.74095703 |
| 42 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.72275569 |
| 43 | regulation of T cell cytokine production (GO:0002724) | 2.66497149 |
| 44 | purine nucleotide salvage (GO:0032261) | 2.64956722 |
| 45 | cellular response to interferon-beta (GO:0035458) | 2.64354665 |
| 46 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61587553 |
| 47 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.61333700 |
| 48 | negative regulation of type 2 immune response (GO:0002829) | 2.60719306 |
| 49 | response to interferon-beta (GO:0035456) | 2.58011824 |
| 50 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.58007279 |
| 51 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.57414698 |
| 52 | Peyers patch development (GO:0048541) | 2.57341003 |
| 53 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.57341003 |
| 54 | negative regulation of telomere maintenance (GO:0032205) | 2.55897465 |
| 55 | drinking behavior (GO:0042756) | 2.55580957 |
| 56 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.54890540 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.53684650 |
| 58 | DNA methylation involved in gamete generation (GO:0043046) | 2.52917388 |
| 59 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.52739754 |
| 60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.52465223 |
| 61 | regulation of B cell differentiation (GO:0045577) | 2.50024905 |
| 62 | aggressive behavior (GO:0002118) | 2.49710442 |
| 63 | positive regulation of T cell differentiation (GO:0045582) | 2.49507433 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 2.48799017 |
| 65 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.48794191 |
| 66 | regulation of autophagic vacuole assembly (GO:2000785) | 2.47778423 |
| 67 | interferon-gamma production (GO:0032609) | 2.46364684 |
| 68 | negative regulation of interleukin-17 production (GO:0032700) | 2.46227427 |
| 69 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.45283042 |
| 70 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.43754473 |
| 71 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.43740450 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 2.43568609 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 2.43022243 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 2.41822243 |
| 75 | cellular response to nicotine (GO:0071316) | 2.41146098 |
| 76 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.40512767 |
| 77 | response to type I interferon (GO:0034340) | 2.40109338 |
| 78 | type I interferon signaling pathway (GO:0060337) | 2.39984188 |
| 79 | cellular response to type I interferon (GO:0071357) | 2.39984188 |
| 80 | positive regulation of digestive system process (GO:0060456) | 2.39174721 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.38821391 |
| 82 | response to host (GO:0075136) | 2.38821391 |
| 83 | response to host defenses (GO:0052200) | 2.38821391 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.38703283 |
| 85 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.38578551 |
| 86 | regulation of vacuole organization (GO:0044088) | 2.38404857 |
| 87 | positive regulation of T cell mediated immunity (GO:0002711) | 2.37415909 |
| 88 | regulation of interleukin-2 production (GO:0032663) | 2.37373592 |
| 89 | positive regulation of catecholamine secretion (GO:0033605) | 2.37131000 |
| 90 | ubiquinone biosynthetic process (GO:0006744) | 2.37050719 |
| 91 | dendritic cell migration (GO:0036336) | 2.35701012 |
| 92 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.35362031 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.34421846 |
| 94 | branched-chain amino acid metabolic process (GO:0009081) | 2.33919277 |
| 95 | neural tube formation (GO:0001841) | 2.33566724 |
| 96 | tryptophan metabolic process (GO:0006568) | 2.33340206 |
| 97 | regulation of alpha-beta T cell activation (GO:0046634) | 2.33211499 |
| 98 | NIK/NF-kappaB signaling (GO:0038061) | 2.32823671 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.32742957 |
| 100 | positive thymic T cell selection (GO:0045059) | 2.32655975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.00325641 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.19758069 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.19890731 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.81540982 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69207717 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.64604059 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49288405 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45319689 |
| 9 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38152258 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.29270375 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18658679 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17242595 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05845800 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95451892 |
| 15 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.94423102 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.93792046 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 1.90113878 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85778787 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.79058255 |
| 20 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.78844327 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.77654537 |
| 22 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76602172 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74883897 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72151036 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.68312372 |
| 26 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.67444438 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65119365 |
| 28 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63756970 |
| 29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55025604 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53602617 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51084010 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47394904 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.43445821 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42431437 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41646055 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39056333 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38749726 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38496290 |
| 39 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.34700497 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34208930 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33043113 |
| 42 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.32939307 |
| 43 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.32424889 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30117631 |
| 45 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28600742 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28321569 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28236641 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.27409538 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25827579 |
| 50 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.25676821 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.22961747 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21249958 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18816687 |
| 54 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.18688046 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18254932 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16101683 |
| 57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15347039 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14308928 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13776206 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.13468180 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12299432 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12027916 |
| 63 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11724835 |
| 64 | P300_27268052_Chip-Seq_Bcells_Human | 1.11190973 |
| 65 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09409617 |
| 66 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08504906 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.07750807 |
| 68 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05096713 |
| 69 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04798005 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03047437 |
| 71 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98800287 |
| 72 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98347267 |
| 73 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98265284 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98165002 |
| 75 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.97007278 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95070204 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93723212 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93169303 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92243653 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 0.92167110 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91260545 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91177296 |
| 83 | P68_20966046_ChIP-Seq_HELA_Human | 0.90419661 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90106627 |
| 85 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.88527878 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88014459 |
| 87 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87299937 |
| 88 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.86020230 |
| 89 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.85898047 |
| 90 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85583872 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85488235 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85292818 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84205240 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83366479 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83142023 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82873127 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82781656 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82771204 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82349994 |
| 100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80420556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.53810788 |
| 2 | MP0003646_muscle_fatigue | 3.04917426 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.87661393 |
| 4 | MP0005671_abnormal_response_to | 2.58680227 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.53343802 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.43530266 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.30311939 |
| 8 | MP0001800_abnormal_humoral_immune | 2.21450049 |
| 9 | MP0000749_muscle_degeneration | 2.19272880 |
| 10 | MP0009785_altered_susceptibility_to | 2.09851119 |
| 11 | MP0002723_abnormal_immune_serum | 2.01731046 |
| 12 | MP0002452_abnormal_antigen_presenting | 1.89725066 |
| 13 | MP0006082_CNS_inflammation | 1.88832492 |
| 14 | MP0000685_abnormal_immune_system | 1.88759583 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 1.87170802 |
| 16 | MP0002332_abnormal_exercise_endurance | 1.86617876 |
| 17 | MP0009278_abnormal_bone_marrow | 1.86138942 |
| 18 | MP0005025_abnormal_response_to | 1.85702437 |
| 19 | MP0003436_decreased_susceptibility_to | 1.83893552 |
| 20 | MP0001790_abnormal_immune_system | 1.82722930 |
| 21 | MP0005387_immune_system_phenotype | 1.82722930 |
| 22 | MP0002419_abnormal_innate_immunity | 1.82618126 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.79413169 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.78791490 |
| 25 | MP0001819_abnormal_immune_cell | 1.76806729 |
| 26 | MP0003303_peritoneal_inflammation | 1.75838067 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.74845923 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.69102599 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.61403149 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.57698630 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.56428535 |
| 32 | MP0000604_amyloidosis | 1.56036205 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.54545926 |
| 34 | MP0004147_increased_porphyrin_level | 1.53892651 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.53156399 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.48753525 |
| 37 | MP0005266_abnormal_metabolism | 1.45609607 |
| 38 | MP0003075_altered_response_to | 1.42703579 |
| 39 | MP0000751_myopathy | 1.42232870 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.41035803 |
| 41 | MP0000716_abnormal_immune_system | 1.38007441 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.36549448 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.32959160 |
| 44 | MP0009764_decreased_sensitivity_to | 1.32885517 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.32713459 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.32534429 |
| 47 | MP0002398_abnormal_bone_marrow | 1.30842395 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.27338098 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.23321019 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.22722958 |
| 51 | MP0005451_abnormal_body_composition | 1.21923053 |
| 52 | MP0009840_abnormal_foam_cell | 1.21723633 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.21691612 |
| 54 | MP0001542_abnormal_bone_strength | 1.20801066 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.19874814 |
| 56 | MP0000343_altered_response_to | 1.19330783 |
| 57 | MP0002722_abnormal_immune_system | 1.18394331 |
| 58 | MP0002106_abnormal_muscle_physiology | 1.17863990 |
| 59 | MP0008469_abnormal_protein_level | 1.15673457 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.13886856 |
| 61 | MP0001968_abnormal_touch/_nociception | 1.11328552 |
| 62 | MP0003329_amyloid_beta_deposits | 1.08823940 |
| 63 | MP0002822_catalepsy | 1.06493578 |
| 64 | MP0005310_abnormal_salivary_gland | 1.05375135 |
| 65 | MP0004130_abnormal_muscle_cell | 1.03099728 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.02048916 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.01612806 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.01612806 |
| 69 | MP0002693_abnormal_pancreas_physiology | 1.00942993 |
| 70 | MP0000759_abnormal_skeletal_muscle | 0.99989955 |
| 71 | MP0002429_abnormal_blood_cell | 0.99879832 |
| 72 | MP0001984_abnormal_olfaction | 0.99172905 |
| 73 | MP0010155_abnormal_intestine_physiology | 0.97921268 |
| 74 | MP0000747_muscle_weakness | 0.97663205 |
| 75 | MP0004233_abnormal_muscle_weight | 0.96645325 |
| 76 | MP0008877_abnormal_DNA_methylation | 0.95658395 |
| 77 | MP0002269_muscular_atrophy | 0.93360013 |
| 78 | MP0001529_abnormal_vocalization | 0.92756593 |
| 79 | MP0005369_muscle_phenotype | 0.92082292 |
| 80 | MP0002405_respiratory_system_inflammati | 0.91532787 |
| 81 | MP0005535_abnormal_body_temperature | 0.90876088 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 0.90494786 |
| 83 | MP0005166_decreased_susceptibility_to | 0.90476761 |
| 84 | MP0002127_abnormal_cardiovascular_syste | 0.89143263 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.88883919 |
| 86 | MP0001905_abnormal_dopamine_level | 0.87385920 |
| 87 | MP0001764_abnormal_homeostasis | 0.84042854 |
| 88 | MP0004084_abnormal_cardiac_muscle | 0.82990140 |
| 89 | MP0003866_abnormal_defecation | 0.82569480 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.82552946 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.82322678 |
| 92 | MP0004043_abnormal_pH_regulation | 0.82263808 |
| 93 | MP0005620_abnormal_muscle_contractility | 0.81515661 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.79404452 |
| 95 | MP0004510_myositis | 0.79153061 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.78848553 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.78666787 |
| 98 | MP0009046_muscle_twitch | 0.77888886 |
| 99 | MP0002733_abnormal_thermal_nociception | 0.76949229 |
| 100 | MP0005330_cardiomyopathy | 0.76000003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.12172586 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 4.16409854 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.05059564 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 4.04488143 |
| 5 | Nemaline bodies (HP:0003798) | 3.56578603 |
| 6 | Rhabdomyolysis (HP:0003201) | 3.39074224 |
| 7 | Myoglobinuria (HP:0002913) | 3.23979788 |
| 8 | Granulocytopenia (HP:0001913) | 3.20391401 |
| 9 | Myopathic facies (HP:0002058) | 3.20202005 |
| 10 | Eosinophilia (HP:0001880) | 3.18278791 |
| 11 | Rimmed vacuoles (HP:0003805) | 3.14267070 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 3.11409125 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07236670 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07236670 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07236670 |
| 16 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.05109550 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 2.88335141 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.82834580 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.82834580 |
| 20 | Dicarboxylic aciduria (HP:0003215) | 2.81176101 |
| 21 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.81176101 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77610814 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 2.71183709 |
| 24 | Abnormality of eosinophils (HP:0001879) | 2.70914262 |
| 25 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.69158092 |
| 26 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.69158092 |
| 27 | Abnormal protein glycosylation (HP:0012346) | 2.69158092 |
| 28 | Abnormal glycosylation (HP:0012345) | 2.69158092 |
| 29 | Ragged-red muscle fibers (HP:0003200) | 2.67048394 |
| 30 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.66493561 |
| 31 | Stomatitis (HP:0010280) | 2.65278622 |
| 32 | Agammaglobulinemia (HP:0004432) | 2.64366553 |
| 33 | Distal arthrogryposis (HP:0005684) | 2.63317643 |
| 34 | Ketosis (HP:0001946) | 2.57510886 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.52938372 |
| 36 | Methylmalonic acidemia (HP:0002912) | 2.50315893 |
| 37 | Increased muscle lipid content (HP:0009058) | 2.50203861 |
| 38 | Recurrent viral infections (HP:0004429) | 2.48316750 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.47327106 |
| 40 | IgG deficiency (HP:0004315) | 2.46552329 |
| 41 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39545422 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 2.38326923 |
| 43 | Facial diplegia (HP:0001349) | 2.35525665 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34325021 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34325021 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34325021 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.33625815 |
| 48 | Neck muscle weakness (HP:0000467) | 2.32821158 |
| 49 | Methylmalonic aciduria (HP:0012120) | 2.32532664 |
| 50 | Calf muscle hypertrophy (HP:0008981) | 2.31357473 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.31272047 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.29970635 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.28786276 |
| 54 | Severe combined immunodeficiency (HP:0004430) | 2.28226181 |
| 55 | Abnormality of the calf musculature (HP:0001430) | 2.26164928 |
| 56 | Leukocytosis (HP:0001974) | 2.24154870 |
| 57 | Ulnar deviation of the wrist (HP:0003049) | 2.23976822 |
| 58 | Clumsiness (HP:0002312) | 2.20587069 |
| 59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19996657 |
| 60 | Hyporeflexia of lower limbs (HP:0002600) | 2.16920395 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16421568 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.16421568 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.12128611 |
| 64 | Ketoacidosis (HP:0001993) | 2.11427747 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.10505689 |
| 66 | Hyperglycinemia (HP:0002154) | 2.10498043 |
| 67 | Frequent falls (HP:0002359) | 2.08591975 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.05863487 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.02915918 |
| 70 | Type II lissencephaly (HP:0007260) | 1.95196424 |
| 71 | Agitation (HP:0000713) | 1.94190586 |
| 72 | Myositis (HP:0100614) | 1.92022428 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91389831 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91389831 |
| 75 | Pulmonary infiltrates (HP:0002113) | 1.90583474 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90021108 |
| 77 | Muscle stiffness (HP:0003552) | 1.88656325 |
| 78 | Abnormality of lateral ventricle (HP:0030047) | 1.87790314 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 1.87380548 |
| 80 | Hepatic necrosis (HP:0002605) | 1.87379016 |
| 81 | Beaking of vertebral bodies (HP:0004568) | 1.86741971 |
| 82 | Malignant hyperthermia (HP:0002047) | 1.86031875 |
| 83 | Abnormality of the columella (HP:0009929) | 1.85326924 |
| 84 | Colitis (HP:0002583) | 1.82635047 |
| 85 | Encephalitis (HP:0002383) | 1.82265651 |
| 86 | Adactyly (HP:0009776) | 1.81350939 |
| 87 | Meningitis (HP:0001287) | 1.80924648 |
| 88 | Exercise intolerance (HP:0003546) | 1.80478913 |
| 89 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.79998841 |
| 90 | Lactic acidosis (HP:0003128) | 1.79708547 |
| 91 | Abnormality of vitamin B metabolism (HP:0004340) | 1.79449293 |
| 92 | Brushfield spots (HP:0001088) | 1.78398434 |
| 93 | Type 2 muscle fiber atrophy (HP:0003554) | 1.76489205 |
| 94 | Hepatocellular necrosis (HP:0001404) | 1.76217509 |
| 95 | Amyotrophic lateral sclerosis (HP:0007354) | 1.76130484 |
| 96 | Xerostomia (HP:0000217) | 1.74992802 |
| 97 | Combined immunodeficiency (HP:0005387) | 1.74860003 |
| 98 | Mitochondrial inheritance (HP:0001427) | 1.74571669 |
| 99 | Abnormality of T cells (HP:0002843) | 1.74172697 |
| 100 | Hypertensive crisis (HP:0100735) | 1.71464318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.10981827 |
| 2 | MAP4K2 | 5.12022743 |
| 3 | OBSCN | 3.48232817 |
| 4 | PINK1 | 3.42373652 |
| 5 | BCKDK | 3.02530168 |
| 6 | MAP4K1 | 2.68327667 |
| 7 | RIPK4 | 2.42100219 |
| 8 | PHKG1 | 2.19423863 |
| 9 | PHKG2 | 2.19423863 |
| 10 | SIK2 | 1.85194030 |
| 11 | CSNK1G3 | 1.84486345 |
| 12 | KIT | 1.69007502 |
| 13 | CSNK1A1L | 1.65709648 |
| 14 | TBK1 | 1.56834835 |
| 15 | PIM2 | 1.54568419 |
| 16 | MAP2K7 | 1.52359298 |
| 17 | TXK | 1.46760418 |
| 18 | GRK6 | 1.43530983 |
| 19 | CSNK1G1 | 1.41769944 |
| 20 | MAPKAPK3 | 1.39700207 |
| 21 | SYK | 1.39428888 |
| 22 | CSNK1G2 | 1.36798393 |
| 23 | TRIM28 | 1.30244505 |
| 24 | FES | 1.29091148 |
| 25 | IRAK2 | 1.25581637 |
| 26 | ADRBK2 | 1.24625632 |
| 27 | CSF1R | 1.22780017 |
| 28 | CDK19 | 1.20262438 |
| 29 | MAP3K1 | 1.17298526 |
| 30 | ARAF | 1.14229804 |
| 31 | GRK5 | 1.12962179 |
| 32 | IKBKB | 1.12049051 |
| 33 | MAP3K11 | 1.11823539 |
| 34 | MATK | 1.10646814 |
| 35 | MAP3K14 | 1.09447696 |
| 36 | GRK7 | 1.03871889 |
| 37 | IKBKE | 0.99940196 |
| 38 | KDR | 0.99763710 |
| 39 | IRAK4 | 0.95458126 |
| 40 | HCK | 0.94984224 |
| 41 | TTN | 0.93409652 |
| 42 | MAP3K4 | 0.92958103 |
| 43 | BTK | 0.90734135 |
| 44 | BMPR2 | 0.87662980 |
| 45 | TESK2 | 0.81885420 |
| 46 | MARK3 | 0.80304078 |
| 47 | DAPK2 | 0.77897126 |
| 48 | IRAK1 | 0.77661770 |
| 49 | ITK | 0.77134418 |
| 50 | RPS6KA5 | 0.74067065 |
| 51 | ZAK | 0.71337151 |
| 52 | DAPK1 | 0.71273234 |
| 53 | MAP2K3 | 0.71099447 |
| 54 | TNK2 | 0.70070818 |
| 55 | LYN | 0.70051347 |
| 56 | TLK1 | 0.69789603 |
| 57 | PRKCQ | 0.67707771 |
| 58 | TESK1 | 0.62729382 |
| 59 | ERN1 | 0.61626981 |
| 60 | MAPK13 | 0.61594507 |
| 61 | TAOK1 | 0.61444194 |
| 62 | MAPK11 | 0.60888717 |
| 63 | MAPK12 | 0.60566438 |
| 64 | JAK2 | 0.59918202 |
| 65 | MOS | 0.58408222 |
| 66 | JAK3 | 0.57664303 |
| 67 | LCK | 0.57560551 |
| 68 | CAMKK2 | 0.56115048 |
| 69 | MAP3K7 | 0.55706949 |
| 70 | MAP2K6 | 0.54019115 |
| 71 | BLK | 0.52016740 |
| 72 | CAMK4 | 0.49940932 |
| 73 | TEC | 0.49900666 |
| 74 | EPHA3 | 0.49656636 |
| 75 | IRAK3 | 0.49039727 |
| 76 | LIMK1 | 0.47228989 |
| 77 | PIM1 | 0.44098915 |
| 78 | RPS6KL1 | 0.42335343 |
| 79 | RPS6KC1 | 0.42335343 |
| 80 | CAMKK1 | 0.41817251 |
| 81 | RPS6KA6 | 0.41115346 |
| 82 | CHUK | 0.40675298 |
| 83 | MAP2K2 | 0.39874341 |
| 84 | MAP2K4 | 0.38384719 |
| 85 | TRPM7 | 0.36773907 |
| 86 | ZAP70 | 0.36397702 |
| 87 | TAOK2 | 0.36166853 |
| 88 | MAPK7 | 0.36127538 |
| 89 | PTK2B | 0.35305664 |
| 90 | MAP3K3 | 0.35221024 |
| 91 | PDK1 | 0.34600270 |
| 92 | JAK1 | 0.33899945 |
| 93 | NEK2 | 0.33897127 |
| 94 | MAPK4 | 0.33097856 |
| 95 | TYK2 | 0.32129810 |
| 96 | GRK1 | 0.31492440 |
| 97 | FLT3 | 0.31307318 |
| 98 | PIK3CA | 0.28945881 |
| 99 | EPHA4 | 0.28551702 |
| 100 | TGFBR2 | 0.28125534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.57433933 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.23240410 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.22400193 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.09951017 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.96058986 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.87914476 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.58533168 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.51959279 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36555167 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.33532171 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.17000620 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02818672 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95381527 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.94130793 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92197967 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91560357 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85172990 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65115345 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.59810732 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57747539 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.55770815 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.54600162 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51693998 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.46880307 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41020056 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38908804 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38885187 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.38072801 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.36036177 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35704475 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23947626 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16814513 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16157756 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.08835102 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02371244 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01681677 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 0.99934899 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95914145 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95043770 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 0.94477078 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92868041 |
| 42 | Measles_Homo sapiens_hsa05162 | 0.91230096 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 0.88972630 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.88827656 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88562105 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88085240 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85264394 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.85069743 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82839690 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79820913 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79818215 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78456333 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77969624 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.77656378 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74296077 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73935235 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73171895 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72789034 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72682119 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.70809218 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.70531563 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69491956 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66400002 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66298300 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66106775 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64822162 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64211135 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.62506453 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61472573 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59239179 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52125942 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51728837 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47892861 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47077789 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45814912 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44164467 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43824851 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.42996377 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38474673 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.36519299 |
| 81 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35314755 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.34799901 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.33688912 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32780889 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32625559 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32381210 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31191777 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.29433989 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.28948059 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.28582673 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28334922 |
| 92 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25527410 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.24821136 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.24717073 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.23575319 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23152521 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21636292 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21128279 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20852624 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.20202123 |

